Randall Severance

Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial

Michel Farnier, Peter J.H. Jones, Randall Severance et al. · Atherosclerosis · 2015 · 186 citations · Full text

Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults

Sam Jackson, Joseph R. Lentino, James Kopp et al. · Vaccine · 2017 · 185 citations · Full text

LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial

Rohit Loomba, Joel Neutel, Rizwana Mohseni et al. · Journal of Hepatology · 2019 · 85 citations

Obesity, Metabolic Syndrome, Hepatology +11

Immunogenicity and safety of a second dose of a measles-mumps-rubella vaccine administered to healthy participants 7 years of age or older: A phase III, randomized study

Remon Abu‐Elyazeed, William Jennings, Randall Severance et al. · Human Vaccines & Immunotherapeutics · 2018 · 37 citations · Full text

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Randall Severance, Howard Schwartz, Ron Dagan et al. · Human Vaccines & Immunotherapeutics · 2021 · 19 citations · Full text